Synthesis of Hsp90 inhibitor dimers as potential antitumor agents

被引:13
|
作者
Muranaka, Kazuhiro [1 ]
Sano, Akiko [2 ]
Ichikawa, Satoshi [1 ]
Matsuda, Akira [1 ]
机构
[1] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan
[2] Taiho Pharmaceut Co Ltd, Hanno Res Ctr, Discovery & Dev Lab 1, Hannou 3578527, Japan
关键词
heat shock protein; Hsp90; PU3; anticancer; structure-based drug design;
D O I
10.1016/j.bmc.2008.04.070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structure-based drug design was used to systematically synthesize PU3-dimers. The cytotoxicity of PU3 dimers 6 against breast cancer cell lines was evaluated, and their potency increased as the length of the bridging linker increased. Among the compounds tested, 6e with a C-20 linker was the most potent and exhibited a 20- to 30-fold increase in activity compared with that of the parent compound 5. Western blot analyses of the cell lysates treated with 6c revealed that 6c resulted in the concentration-dependent degradation of the Hsp90 client protein Her2, which is consistent with other Hsp90 inhibitors. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5862 / 5870
页数:9
相关论文
共 50 条
  • [1] Efficient synthesis of Hsp90 inhibitor dimers as potential antitumor agents
    Sekiguchi, Hironori
    Muranaka, Kazuhiro
    Osada, Akiko
    Ichikawa, Satoshi
    Matsuda, Akira
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (15) : 5732 - 5737
  • [2] Design and Synthesis of an Hsp90 and HDAC Dual Inhibitor as Antitumor Agent
    Wu, Jiyong
    Wang, Dongbo
    Nie, Jing
    Zhang, Di
    Sun, Lei
    Kan, Shifeng
    Xu, Wei
    LETTERS IN DRUG DESIGN & DISCOVERY, 2023, 20 (06) : 619 - 627
  • [3] Recent Advances in Hsp90 Inhibitors as Antitumor Agents
    Messaoudi, S.
    Peyrat, J. F.
    Brion, J. D.
    Alami, M.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2008, 8 (07) : 761 - 782
  • [4] HSP90 INHIBITOR-DRUG CONJUGATES (HDC) WITH ANTITUMOR AGENTS TARGETING HEMATOLOGICAL MALIGNANCES
    Rao, P. E.
    Proia, D.
    Chu, J.
    Sang, J.
    Ying, W.
    Chimmanamada, D.
    Kowalczyk-Przewloka, T.
    Jiang, J.
    HAEMATOLOGICA, 2014, 99 : 100 - 100
  • [5] Total synthesis of the Hsp90 inhibitor geldanamycin
    Oin, Hua-Li
    Panek, James S.
    ORGANIC LETTERS, 2008, 10 (12) : 2477 - 2479
  • [6] Concise synthesis of pochonin A, an HSP90 inhibitor
    Moulin, E
    Barluenga, S
    Winssinger, N
    ORGANIC LETTERS, 2005, 7 (25) : 5637 - 5639
  • [7] Mechanistic Asymmetry in Hsp90 Dimers
    Flynn, Julia M.
    Mishra, Parul
    Bolon, Daniel N. A.
    JOURNAL OF MOLECULAR BIOLOGY, 2015, 427 (18) : 2904 - 2911
  • [8] MEDI 75-Synthesis of analogs of trienomycin A, a potential inhibitor of Hsp90
    Calvet, Geraldine
    Blagg, Brian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [9] Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas
    Wei, Shiyou
    Yin, Delong
    Yu, Shengnan
    Lin, Xiang
    Savani, Milan R.
    Du, Kuang
    Ku, Yin
    Wu, Di
    Li, Shasha
    Liu, Hao
    Tian, Meng
    Chen, Yaohui
    Bowie, Michelle
    Hariharan, Seethalakshmi
    Waitkus, Matthew
    Keir, Stephen T.
    Sugarman, Eric T.
    Deek, Rebecca A.
    Labrie, Marilyne
    Khasraw, Mustafa
    Lu, Yiling
    Mills, Gordon B.
    Herlyn, Meenhard
    Wu, Kongming
    Liu, Lunxu
    Wei, Zhi
    Flaherty, Keith T.
    Abdullah, Kalil
    Zhang, Gao
    Ashley, David M.
    CLINICAL CANCER RESEARCH, 2022, 28 (10) : 2180 - 2195
  • [10] ALTERNATE SYNTHESIS OF HSP90 INHIBITOR AT13387
    Liang, Cuirong
    Gu, Lingling
    Yang, Yang
    Chen, Xin
    SYNTHETIC COMMUNICATIONS, 2014, 44 (16) : 2416 - 2425